Literature DB >> 15870291

Generation and characterization of Rgs4 mutant mice.

Nicolas Grillet1, Alexandre Pattyn, Candice Contet, Brigitte L Kieffer, Christo Goridis, Jean-François Brunet.   

Abstract

RGS proteins are negative regulators of signaling through heterotrimeric G protein-coupled receptors and, as such, are in a position to regulate a plethora of biological phenomena. However, those have just begun to be explored in vivo. Here, we describe a mouse line deficient for Rgs4, a gene normally expressed early on in discrete populations of differentiating neurons and later on at multiple sites of the central nervous system, the cortex in particular, where it is one of the most highly transcribed Rgs genes. Rgs4(lacZ/lacZ) mice had normal neural development and were viable and fertile. Behavioral testing on mutant adults revealed subtle sensorimotor deficits but, so far, supported neither the proposed status of Rgs4 as a schizophrenia susceptibility gene (by showing intact prepulse inhibition in the mutants) nor (unlike another member of the Rgs family, Rgs9) a role of Rgs4 in the acute or chronic response to opioids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870291      PMCID: PMC1087729          DOI: 10.1128/MCB.25.10.4221-4228.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Dynamic expression of RGS4 in the developing nervous system and regulation by the neural type-specific transcription factor Phox2b.

Authors:  Nicolas Grillet; Véronique Dubreuil; Héloïse D Dufour; Jean-François Brunet
Journal:  J Neurosci       Date:  2003-11-19       Impact factor: 6.167

2.  Support for RGS4 as a susceptibility gene for schizophrenia.

Authors:  Nigel M Williams; Anna Preece; Gillian Spurlock; Nadine Norton; Hywel J Williams; Robin G McCreadie; Paul Buckland; Val Sharkey; Kodavali V Chowdari; Stanley Zammit; Vishwajit Nimgaonkar; George Kirov; Michael J Owen; Michael C O'Donovan
Journal:  Biol Psychiatry       Date:  2004-01-15       Impact factor: 13.382

3.  Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine.

Authors:  Martine Garnier; Paola F Zaratin; Giovanna Ficalora; Maurizio Valente; Laura Fontanella; Man-Hee Rhee; Kendall J Blumer; Mark A Scheideler
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

4.  Essential role for RGS9 in opiate action.

Authors:  Venetia Zachariou; Dan Georgescu; Nick Sanchez; Zia Rahman; Ralph DiLeone; Olivier Berton; Rachael L Neve; Laura J Sim-Selley; Dana E Selley; Stephen J Gold; Eric J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

Review 5.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

6.  Confirming RGS4 as a susceptibility gene for schizophrenia.

Authors:  Derek W Morris; Alana Rodgers; Kevin A McGhee; Siobhan Schwaiger; Paul Scully; John Quinn; David Meagher; John L Waddington; Michael Gill; Aiden P Corvin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-02-15       Impact factor: 3.568

7.  Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure.

Authors:  K Mary Tang; Guang-rong Wang; Ping Lu; Richard H Karas; Mark Aronovitz; Scott P Heximer; Kevin M Kaltenbronn; Kendall J Blumer; David P Siderovski; Yan Zhu; Michael E Mendelsohn; Mary Tang; Guang Wang
Journal:  Nat Med       Date:  2003-11-09       Impact factor: 53.440

8.  The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling.

Authors:  Hyeseon Cho; Kathleen Harrison; Owen Schwartz; John H Kehrl
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  Effects of nandrolone on acute morphine responses, tolerance and dependence in mice.

Authors:  Evelyne Célérier; Maryam T Yazdi; Anna Castañé; Sandy Ghozland; Fred Nyberg; Rafael Maldonado
Journal:  Eur J Pharmacol       Date:  2003-03-28       Impact factor: 4.432

10.  Regulation of RGS proteins by chronic morphine in rat locus coeruleus.

Authors:  Stephen J Gold; Ming-Hu Han; Amy E Herman; Yan G Ni; Cindy M Pudiak; George K Aghajanian; Rong-Jian Liu; Bryan W Potts; Susanne M Mumby; Eric J Nestler
Journal:  Eur J Neurosci       Date:  2003-03       Impact factor: 3.386

View more
  45 in total

1.  Pleiotropic phenotype of a genomic knock-in of an RGS-insensitive G184S Gnai2 allele.

Authors:  Xinyan Huang; Ying Fu; Raelene A Charbeneau; Thomas L Saunders; Douglas K Taylor; Kurt D Hankenson; Mark W Russell; Louis G D'Alecy; Richard R Neubig
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 2.  Drosophila, a genetic model system to study cocaine-related behaviors: a review with focus on LIM-only proteins.

Authors:  Ulrike Heberlein; Linus T-Y Tsai; David Kapfhamer; Amy W Lasek
Journal:  Neuropharmacology       Date:  2008-07-24       Impact factor: 5.250

3.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

Review 4.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

5.  Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction.

Authors:  David L Roman; John R Traynor
Journal:  J Med Chem       Date:  2011-09-29       Impact factor: 7.446

Review 6.  Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.

Authors:  Chi-Ying Lin; Akira Sawa; Hanna Jaaro-Peled
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

7.  Differential modulation of mu-opioid receptor signaling to adenylyl cyclase by regulators of G protein signaling proteins 4 or 8 and 7 in permeabilised C6 cells is Galpha subtype dependent.

Authors:  Jeffery N Talbot; David L Roman; Mary J Clark; Rebecca A Roof; John J G Tesmer; Richard R Neubig; John R Traynor
Journal:  J Neurochem       Date:  2009-11-30       Impact factor: 5.372

Review 8.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

9.  Gene expression profiling of rat cerebral cortex development using cDNA microarrays.

Authors:  Ki-Hwan Lee; Dong-Hyun Yu; Yong-Sung Lee
Journal:  Neurochem Res       Date:  2008-11-06       Impact factor: 3.996

Review 10.  R9AP and R7BP: traffic cops for the RGS7 family in phototransduction and neuronal GPCR signaling.

Authors:  Muralidharan Jayaraman; Hao Zhou; Lixia Jia; Matthew D Cain; Kendall J Blumer
Journal:  Trends Pharmacol Sci       Date:  2008-11-29       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.